Tower Cold Chain, a Cold Chain Technologies company, a leading provider of passive temperature-controlled containers, has expanded its global footprint following its recent acquisition by Cold Chain Technologies (CCT). This strategic integration enhances both companies' capabilities, offering a comprehensive network of temperature-controlled solutions to meet the growing global demand for pharmaceutical and life sciences shipments.
With the combined resources of Tower and CCT, customers now benefit from a vastly expanded hub network featuring three Centres of Excellence and 54 regional hubs spanning 26 countries, enabling broader geographic coverage and enhanced customer service.
Ahead of the acquisition, Tower Cold Chain had recently launched new hubs in Toronto, Canada, and Hyderabad, India, strengthening its presence across the Americas and Asia-Pacific regions.
Tower’s presence in regions such as South America and parts of APAC has now been significantly bolstered through CCT’s robust infrastructure. This expansion empowers customers to access a broader portfolio of solutions, combining Tower’s advanced reusable passive containers with CCT’s reliable single-use packaging options.
For Cold Chain Technologies, the acquisition strengthens its position in the EMEA region, where Tower Cold Chain already had a strong foothold.
The newly strengthened network not only boosts logistics efficiency but also advances the company’s sustainability goals by reducing idle time and minimising transport distances for reusable containers. Customers now benefit from improved regional support, faster delivery times, and streamlined product return processes, ensuring a more seamless and sustainable service experience.
Niall Balfour, CEO of Tower Cold Chain, commented: “We are delighted to provide our customers with greater availability and proximity of our expanded range of products and services through our strengthened global hub network.
“This development not only enhances our reach but also reinforces our commitment to delivering high-performance, temperature-controlled solutions with both global scalability and local expertise.
“After what was already a very successful year for Tower Cold Chain, the acquisition marks a significant milestone, positioning us for continued success as we head into 2025.”
Tower delivers proven physical and temperature protection for pharmaceutical and life science products and our robust, reliable, and reusable containers are the essential link in the stability of the cold chain.
Headquartered in the UK, we operate a global network ensuring availability and easy access to our products for all customers.
We are trusted by global pharmaceutical, logistics and airline companies and our experienced team, supported by a centralised quality-management system, reinforces customer confidence that our shipping facilities will meet requirements throughout the supply chain. Our patented design technology ensures our solutions meet the pharmaceutical industry performance standard, providing a minimum of 120 hours temperature compliance in any environment, anywhere in the world.
We work closely with our customers, realising their requirements and how we can address emerging needs. and to deliver customer-focused innovation in temperature-controlled protection.
In 2024, Tower Cold Chain was acquired by Cold Chain Technologies (CCT), a leading global provider of thermal packaging and digital solutions for the shipment of temperature-sensitive material for the life sciences industry. With more than 50 years of proven product assurance in transit, CCT has built a reputation as the life sciences industry’s most innovative and dependable provider.
For Tower sales enquiries please contact:
Caroline Suard, Global Marketing Manager, Tower Cold Chain
For Tower media enquiries please contact:
Simon Kinnear, Rhiannon Hopper, or Hannah Woods, Nielsen McAllister
Tel: +44 (0)1332 293939